New Era of Regenerative Medicine
Power of Repair & Reborn
StemCell
New Power of Regenerative Medicine
We believe in the transformative power of stem cells. With their unparalleled regenerative abilities, our dedicated team of experts is focused on advancing stem cell research and cooperating with a lot of biomedical company of Shang-Hai, Taipei and Japan, to bring groundbreaking solutions to patients. Whether you're seeking alternative therapies or are curious about stem cell applications, R2 is dedicated to offering comprehensive information and support. Experience the future of healthcare with us.
Evidence supporting that HUC-MSCs therapy is significant decrease in TNF-α and IL-17, reducing chronic inflammation , along with the observed improvements in quality of life and physical performance, highlight the potential of HUC-MSCs for intervening and preventing of the physical decline associated with aging frailty.
Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study
Zhu et al. Stem Cell Research & Therapy (2024) 15:122
What is umbilical cord mesenchymal stem cell (UC-MSC) ?
UC-MSCs are a kind of mesenchymal stem cell derived from neonatal umbilical cord tissue with abundant material sources, easy amplification, strong plasticity, low immunogenicity, high migration and homing activity, exocrine secretion, and the secretion of a variety of cytokines.
Compared with other MSCs, such as adipose mesenchymal stem cells (ADMSCs), bone marrow mesenchymal stem cells (BMSCs), dental pulp stem cells (DPSCs), embryonic stem cells (ASCs), and neural stem cells (NSCs); UC-MSCs have no ethical or safety challenges, are easier to obtain, expand and store and can fully meet clinical needs.
After UC-MSC 2 times treatment
Participants between ages of 60 and 80 years.
The significant decrease in TNF-α and IL-17, along with the observed improvements in quality of life and physical performance, including timed up and go (TUG) tests, muscle grip strength and 4mins walking test (4MWT), highlight the potential of Human Umbilical Cord-MSCs as a therapeutic option for intervening and preventing of the physical decline associated with aging frailty.
01
The skin shows structural and functional degradation under the action of internal and external factors, and UC-MSCs rejuvenate it by promoting injury repair and regeneration through anti-inflammatory, antioxidative, and anti-glycosylation mechanisms.
02
UC-MSCs exert their anti-inflammatory effect mainly by secreting cytokines, growth factors, anti-inflammatory factors, and exocrine factors to reduce the inflammatory response and enhance tissue repair.
03
UCMSC treatment can enhance the ability of cells to scavenge free radicals, improve the antioxidant stress function of skin, and play a positive role in reducing cell senescence caused by oxidative stress.
